Are Voren (diclofenac), cetirizine, Oxynase nasal spray (oxymetazoline), ivy‑leaf (Hedera helix) lozenges, and bromhexine safe for use while breastfeeding?

Safety of Medications During Breastfeeding

Most of these medications can be used during breastfeeding with appropriate precautions, though cetirizine and oxymetazoline nasal spray require the most caution, while diclofenac (Voren), bromhexine, and ivy leaf appear reasonably safe based on available evidence.

Individual Medication Assessment

Voren (Diclofenac) - SAFE

• NSAIDs are generally considered compatible with breastfeeding 1
• Diclofenac transfers into breast milk in very low amounts with relative infant dose typically below 10% 2
• Most NSAIDs result in low infant exposure via breastmilk and are considered safe, preferable to aspirin 3
• Use the lowest effective dose for the shortest duration

Cetirizine - USE WITH CAUTION

• The FDA label explicitly states "not recommended" during breastfeeding 4
• However, clinical practice guidelines suggest loratadine or cetirizine should be preferred antihistamines as they have been most extensively used 5
• Antihistamines may theoretically reduce milk production 5
• If needed, take immediately after breastfeeding to minimize infant exposure
• Monitor infant for sedation or irritability

Oxynase (Oxymetazoline) Nasal Spray - USE WITH CAUTION

• Oral decongestants should not be used during breastfeeding 6
• The FDA label advises to "ask a health professional before use" 7
• Topical nasal decongestants have minimal systemic absorption compared to oral forms
• Limit use to 3-5 days maximum to avoid rebound congestion
• Apply immediately after breastfeeding to minimize any potential exposure

Ivy Leaf (Hedera helix) Drops/Lozenges - LIKELY SAFE

• No specific breastfeeding data available in guidelines
• Recent research shows ivy leaf compounds (α-Hederin, Hederacoside C) are used safely in respiratory formulations for adults and children 8
• As a commonly used over-the-counter respiratory remedy with extensive pediatric use, the safety profile appears favorable
• Herbal products generally have lower systemic absorption when used as lozenges

Bromhexine - LIKELY SAFE

• No specific contraindications found in breastfeeding guidelines
• Mucolytics are generally considered safe for breastfeeding patients 9
• Minimal data exists, but the drug's properties suggest low transfer into breast milk
• Use standard therapeutic doses

Key Clinical Considerations

Common Pitfalls to Avoid:

• Don't automatically discontinue breastfeeding based on package insert warnings alone—these are often overly conservative
• Don't recommend "pump and dump" unless specifically indicated (not needed for any of these medications)
• Don't withhold necessary maternal treatment out of excessive caution

Timing Strategy:

• Take all medications immediately after breastfeeding or before the infant's longest sleep period
• This maximizes the interval between peak drug levels and next feeding

Monitoring:

• Watch for infant sedation, irritability, or feeding changes with cetirizine
• Monitor for any unusual symptoms with the combination of multiple medications
• If the infant shows any concerning symptoms, discontinue the most recently added medication first

Duration Considerations:

• Use oxymetazoline nasal spray for ≤3-5 days only
• Use NSAIDs at lowest effective dose for shortest duration
• Bromhexine and ivy leaf can be used for typical respiratory illness duration (7-10 days)

The evidence strongly supports that maternal treatment should not be withheld when clinically indicated, as untreated maternal illness poses greater risks to successful breastfeeding than minimal medication exposure 10, 9.